Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cardiome Pharma Corp (NASDAQ:CRME)

1.49
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
1.29
Today|||52-Week Range
4.84
-46.01%
Year-to-Date
No recent news for Cardiome Pharma Corp.

Today’s Trading

Previous close1.49
Today’s open1.46
Day’s range1.43 - 1.52
Volume81,388
Average volume (3 months)161,627
Market cap$51.6M
Data as of 3:59pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)+41.79%
Earnings growth (this year)+10.48%
Earnings growth (next 5 years)--
Revenue growth (last year)+20.78%
P/E ratioNM
Price/Sales2.80
Price/Book1.40

Competitors

 Today’s
change
Today’s
% change
AFMDAffimed NV0.000.00%
XOMAXOMA Corp0.000.00%
ZYNEZynerba Pharmaceutic...0.000.00%
AGTCApplied Genetic Tech...0.000.00%
Data as of 4:00pm ET, 12/15/2017

Financials

Next reporting dateMarch 28, 2018
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$25.3M
Annual profit (last year)-$19.6M
Net profit margin-77.68%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bill Hunter
Chief Operating Officer
Sheila M. Grant
Corporate headquarters
Vancouver, British Columbia

Forecasts